Date | Compound | Laboratory | Indication | Type of Information |
---|---|---|---|---|
2016-02-03 | engineered skin substitute | Amarantus BioScience (USA – CA) | giant congenital melanocytic nevus deep-partial and full-thickness thermal burns |
Granting of a patent |
2016-01-29 | mesencephalic-astrocyte-derived neurotrophic factor | Amarantus BioScience (USA – CA) | Parkinson's disease |
Granting of a patent |
2016-02-11 | epacadostat | Incyte (USA - DE) | stage IIB-IV melanoma |
Granting of the orphan status in the US |
2016-02-08 | evinacumab | Regeneron Pharmaceuticals (USA - NY) | homozygous familial hypercholesterolemia |
Granting of the orphan status in the US |
2016-02-08 | glyburide | Remedy Pharmaceuticals (USA - NY) | acute subarachnoid hemorrhage |
Granting of the orphan status in the US |
2016-02-23 | growth hormone releasing hormone, 1-44 human amide | Hollenbeck Pharmaceuticals (USA - DE) | growth hormone deficiency |
Granting of the orphan status in the US |
2016-02-04 | human recombinant dual-variable domain immunoglobulin G1 monoclonal antibody that selectively neutralizes tumor necrosis factor-alpha and interkeukin-17A | Abbvie (USA - IL) | pediatric patients 0 to <18 yrs of age with oligoarticular-course and polyarticular-course juvenile idiopathic arthritis |
Granting of the orphan status in the US |
2017-03-20 | inebilizumab | MedImmune (USA - global biologics arm of AstraZeneca (UK) | neuromyelitis optica and neuromyelitis optica spectrum disorders | Granting of the orphan status in the EU |
2016-02-02 | ibrutinib | Pharmacyclics (USA - CA), now Abbvie (USA - IL) | patients with extranodal marginal zone lymphoma (mucosa associated lymphoid tissue [MALT type] lymphoma) |
Granting of the orphan status in the US |
2017-08-02 | ibrutinib | Pharmacyclics (USA - CA), now Abbvie (USA - IL) | chronic graft versus host disease (cGVHD) | Granting of a Market Authorisation in the US |
2016-02-04 | midazolam | Meridian Medical Technologies (USA - MD, a Pfizer company (USA - NY) | status epilepticus |
Granting of the orphan status in the US |
2016-02-17 | midazolam | Shire (UK - USA) | status epilepticus |
Granting of the orphan status in the US |
2016-02-18 | midazolam | Meridian Medical Technologies (USA - MD, a Pfizer company (USA - NY) | seizures induced by organophosporous insecticide poisoning |
Granting of the orphan status in the US |
2016-04-06 | 1-(2-Nitro-imidazolyl)-3-[18F]fluoro-2-propanol; 1H-1-(3-[18F]fluoro-2-hydroxypropyl0-2-nitroimidazole (18F-Misonidazole) | Advanced Imaging Projects (USA - Fl) | diagnostic for management of glioma |
Granting of the orphan status in the US |
2016-06-08 | fosbretabulin tromethamine | Mateon Therapeutics (USA - CA), previously known as Oxigene (USA - CA) | glioma |
Granting of the orphan status in the US |
2016-05-26 | recombinant, non-pathogenic poliovirus:rhinovirus chimera that consists of the genome of the live attenuated poliovirus serotype 1 vaccine with its cognate IRES element replaced with that of HRV2 | Darell D. Bigner, Duke University Medical Center (USA - NC) | glioma |
Granting of the orphan status in the US |
2016-02-02 | oligodendrocyte progenitor cells | Asterias Biotherapeutics (USA - CA) | acute spinal cord injury |
Granting of the orphan status in the US |
2016-02-24 | ombitasvir/paritaprevir/ritonavir | Abbvie (USA - IL) | pediatric patients with chronic hepatitis C virus infection |
Granting of the orphan status in the US |
2016-02-17 | pembrolizumab (MK-3475) | Merck&Co (USA - NJ) | multiple myeloma | Granting of the orphan status in the US |
2016-02-24 | rapamycin | DSLP (New Zealand) | facial angiofibromas (FA) associated with tuberous sclerosis complex (TSC) |
Granting of the orphan status in the US |
© 2024 Biopharmanalyses - Powered by Samacom+